Inhibikase Therapeutics, Inc. was added to several prominent Russell indices on June 30, 2025. These inclusions encompass the Russell 3000 Index, Russell 3000 Value Index, and Russell 3000 Growth Index.
The company also gained entry into the Russell 2500 Index, Russell 2500 Value Index, and Russell 2000 Dynamic Index. Furthermore, Inhibikase was added to the Russell Microcap Index, Russell Small Cap Comp Growth Index, and Russell Small Cap Comp Value Index.
These additions to widely followed indices can enhance the company's market visibility and potentially increase demand for its shares from passive investment funds that track these benchmarks.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.